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Introduction {#sec1}
============

Mouse embryonic stem cells (mESCs) are cells derived from inner cell mass (ICM) that self-renew indefinitely in culture and can give rise to all somatic cell types both in vitro and in vivo ([@bib12; @bib43; @bib48]). The balance between self-renewal and differentiation is maintained by a milieu of transcription factors (TFs) ([@bib23; @bib62]), epigenetic modifiers ([@bib1; @bib33; @bib37]), and signaling cascades ([@bib31; @bib51]). Many ESC-specific TFs such as Nanog ([@bib5]), Rex1 ([@bib64]), Klf4 ([@bib51; @bib64]), and Tbx3 ([@bib51]) are heterogeneously expressed in a population of mESCs ([@bib13; @bib40]). These factors display low and high protein expression levels ([@bib5; @bib64]). In the absence of some of these TFs (like Nanog), mESCs can maintain self-renewal and pluripotency ([@bib5]).

Expression of TFs like Nanog, Sox2, Esrrb, Klf4, and Tbx3 is controlled by external signaling cues ([@bib51]). Wnt signaling pathway has been widely studied in development ([@bib53]), plays important roles in maintaining pluripotency ([@bib60; @bib74]), and is important for acquisition of pluripotency during induced pluripotent stem cell (iPSC) reprogramming ([@bib21; @bib41]). Downstream of Wnt ligand/receptor binding, the inhibition of GSK3β is necessary for stabilization of β-CATENIN ([@bib53]). Inhibition of GSK3β and Mapk signaling with small molecules maintains a naive pluripotent state in mESCs ([@bib59; @bib74]). Wnt signaling stabilizes the mESC state in limiting amounts of LIF ([@bib54]). Wnt3a prevents mESC differentiation from a naive to an epiblast-like or primed state ([@bib60]). Apart from its role in maintenance of pluripotency, Wnt signaling is also required for differentiation of mESCs into early mesoderm derivatives ([@bib15]). Specifically, Wnt3 and Wnt8a are necessary for mesoderm differentiation ([@bib28; @bib35]). During in vivo development, Wnt signaling is required for formation of primitive streak and mesoderm ([@bib2; @bib44; @bib69]). In summary, Wnt signaling is required both for stabilization of an undifferentiated pluripotent state and for promoting early mesoderm differentiation.

Expression of Tbx3 is regulated by Wnt signaling in mESCs ([@bib27; @bib56]) and cancer ([@bib57]). Tbx3, the only member of its subfamily expressed in the ICM, is required for maintenance of ESC state ([@bib6; @bib19; @bib23]). Tbx3 maintains self-renewal of mESCs in absence of LIF, a property shared by Nanog and Klf4 ([@bib19]). Tbx3 overexpressed with Oct4, Sox2, and Klf4 during iPSC-reprogramming improves germline competence of fully reprogrammed iPSCs ([@bib19]). Tbx3 overexpression also improves the efficiency of cell fusion-based reprogramming ([@bib19]). However, in vivo, Tbx3 null embryos survive until E10.5 ([@bib9]), beyond the blastocyst stage.

Many ESC-specific TFs like Oct4, Nanog, Sox2 ([@bib45; @bib62]), and Sall4 ([@bib34]) play important roles during early differentiation in addition to their roles in repressing differentiation of ESCs ([@bib36]). Tbx3 promotes the formation of the mesendoderm lineage and is expressed both in ESCs and in vivo during primitive streak formation ([@bib26; @bib67]). Furthermore, Tbx3 is required for generation of extraembryonic endoderm cells ([@bib38; @bib58]) and for opening up of *Eomes* promoter during differentiation to definitive endoderm ([@bib26]). However, the mechanisms by which Tbx3 regulates transition from a stable pluripotent state into differentiated progenitors remain unclear. Here, we explore how Tbx3 modulates the response of extracellular signaling and maintains balance between mESC self-renewal and differentiation. We isolate an alternate and stable pluripotent state in the absence of Tbx3 and identify Dppa3 (Stella/PGC7) as a direct downstream target of Tbx3. We present a model in which the Wnt/Tbx3/Dppa3 signaling-TF axis controls specification of mESCs into mesoderm lineage.

Results {#sec2}
=======

A Subpopulation of mESCs Maintains a Tbx3 Null Pluripotent State {#sec2.1}
----------------------------------------------------------------

Tbx3 plays an important role in the maintenance of the mESC self-renewal state ([@bib19; @bib23]). Upon RNAi-mediated Tbx3 depletion, mESCs differentiate even in the presence of LIF ([@bib23]). We used a genetic complementation "rescue" system to control the expression of Tbx3 in ESCs ([Figure S1](#mmc1){ref-type="supplementary-material"}A). In this system, called Tbx3R, endogenous Tbx3 is depleted by a constitutively expressed short-hairpin (sh) RNA and replaced with an exogenous shRNA-immune Tbx3 cDNA under the control of Doxycycline (Dox) ([@bib23]). Five days after knockdown of Tbx3 (−Dox), mESCs lose their characteristic ESC-like morphology and alkaline phosphatase (AP) staining ([Figure S1](#mmc1){ref-type="supplementary-material"}B). During the 5-day time course, mESCs also downregulate expression of pluripotency genes and upregulate differentiation markers ([Figure S1](#mmc1){ref-type="supplementary-material"}C). Interestingly, upon prolonged culture of Tbx3-depleted cells, rare colonies with an ESC-like morphology emerge in a population of differentiating cells ([Figure S1](#mmc1){ref-type="supplementary-material"}D). We picked and expanded three of these colonies (clones 15, 16, and 17) for weeks in the absence of Dox ([Figure 1](#fig1){ref-type="fig"}A, right). We also picked and expanded some colonies grown in the presence of Dox (clones 27, 28, and 29) as controls ([Figure 1](#fig1){ref-type="fig"}A, left). All of the six clones maintained ESC-like morphology and AP activity ([Figure 1](#fig1){ref-type="fig"}A). *Tbx3* mRNA level was reduced in colonies without Dox, but they continued to express ESC markers such as *Oct4*, *Nanog*, *Sox2*, *Esrrb*, and *Tcl1* ([Figure 1](#fig1){ref-type="fig"}B). The level of TBX3 protein was reduced in colonies without Dox ([Figures 1](#fig1){ref-type="fig"}C and 1D), but they continued to express OCT4 and SOX2 proteins ([Figure 1](#fig1){ref-type="fig"}D). Tbx3 mRNA and protein is heterogeneously expressed in populations of mESCs ([@bib30; @bib40; @bib51]). We confirmed these results by analyzing the expression of *Tbx3* mRNA in single mESCs discussed later. We therefore postulated that Tbx3 function might be dispensable in a subpopulation of mESCs upon long-term culture.

To explore this, we generated Tbx3 null mESCs from Tbx3 heterozygous (Tbx3^+/N^) mESCs ([@bib9]) using two approaches. First, Tbx3^N/N^ cells were generated via homologous recombination by culturing Tbx3^+/N^ cells in high concentrations of G418 ([Figure S2](#mmc1){ref-type="supplementary-material"}A). Second, Tbx3^N/P^ cells were generated by targeting the WT allele in Tbx3^+/N^ cells ([Figure S2](#mmc1){ref-type="supplementary-material"}A). We confirmed the targeted alleles by genomic PCR and Southern blotting ([Figures S2](#mmc1){ref-type="supplementary-material"}B and 2C). Loss of TBX3 protein expression was confirmed ([Figure S2](#mmc1){ref-type="supplementary-material"}D). Tbx3^N/N^ cells also maintained a normal karyotype in culture ([Figure S2](#mmc1){ref-type="supplementary-material"}E). Both Tbx3^N/P^ and Tbx3^N/N^ cells maintain ESC-like morphology and AP activity ([Figure 2](#fig2){ref-type="fig"}A). Single Tbx3^N/N^ cells retain the ability to form AP-positive colonies with efficiencies equal to WT and Tbx3^+/N^ cells ([Figure 2](#fig2){ref-type="fig"}B). We tested the developmental potential of Tbx3^N/N^ and Tbx3^N/P^ mESCs using the blastocyst injection assay. Tbx3^+/N^ cells were used as control in the experiment. To mark ESCs and their descendants in chimeras, Tbx3^+/N^ and Tbx3^N/P^ cells were infected with lentiviral tdTomato vector, and Tbx3^N/N^ cells were infected with lentiviral eGFP vector. Both Tbx3^N/N^ and Tbx3^N/P^ cells extensively contributed to various tissues of E10.5 embryos indicated by expression of GFP or tdTomato throughout the chimeric embryos ([Figure 2](#fig2){ref-type="fig"}C; [Table S6](#mmc7){ref-type="supplementary-material"}). It has also been reported that Tbx3^N/N^ embryos, derived by mating Tbx3^+/N^ mice, give rise to live embryos that survive without any apparent defects until E10.5, after which they exhibit a variety of defects in various tissues, including the yolk sac, limbs, and emergent mammary glands ([@bib9]). The mRNA expression levels of a selected panel of ESC genes also did not change significantly (\>2-fold) between Tbx3^+/+^, Tbx3^+/N^, Tbx3^N/N^, and Tbx3^N/P^ mESCs with the exception of *Dppa3*, which is discussed in detail later ([Figure 2](#fig2){ref-type="fig"}D). To further characterize Tbx3 null mESCs, we used a heterokaryon-based reprogramming assay ([@bib55]). We tested the ability of Tbx3^N/N^ mESCs to confer an ESC-like state on human B cells following cell fusion ([Figure S2](#mmc1){ref-type="supplementary-material"}F). The starting B cells do not express human *TBX3* mRNA as shown using human-specific primers ([Figure S2](#mmc1){ref-type="supplementary-material"}G). Tbx3^N/N^ mESCs robustly induce a human ESC gene expression signature ([Figure S2](#mmc1){ref-type="supplementary-material"}H) onto human B cells. Tbx3 null mESCs therefore retain the ability to reprogram differentiated cells into an ESC-like state, a property of self-renewing mESCs.

To rule out the possibility of cell culture side effects, we derived Tbx3^−/−^ mESCs from Tbx3^−/−^ blastocysts by mating Tbx3^+/N^ mice ([Figure S3](#mmc1){ref-type="supplementary-material"}A; [Table S5](#mmc6){ref-type="supplementary-material"}). We refer to these in vivo derived cells as T3Blast mESCs. T3Blast^+/+^, T3Blast^+/N^, and T3Blast^N/N^ cells maintain ESC-like morphology and stain positive for AP activity ([Figure S3](#mmc1){ref-type="supplementary-material"}B). The mRNA expression levels of a selected panel of mESC genes did not change significantly (\>2-fold) between T3Blast^+/+^, T3Blast^+/N^, and T3Blast^N/N^ cells with the exception of *Dppa3* ([Figure S3](#mmc1){ref-type="supplementary-material"}C). To further characterize the function of Tbx3 in vivo, we assessed Tbx3^+/+^, Tbx3^+/−^, and Tbx3^−/−^ blastocysts at stages E3.75 and E4.5. They had no apparent abnormality in size ([Figures S3](#mmc1){ref-type="supplementary-material"}D and S3E) and cell number ([Figure S3](#mmc1){ref-type="supplementary-material"}E; [Table S5](#mmc6){ref-type="supplementary-material"}). The number of cells expressing GATA6 and NANOG proteins, markers for primitive endoderm (PrE) and epiblast, respectively, were also assessed in the blastocysts. No significant difference was found between Tbx3^+/+^, Tbx3^+/−^, and Tbx3^−/−^ blastocysts at stages E3.75 and E4.5 ([Figure S3](#mmc1){ref-type="supplementary-material"}F). In summary, our data suggest that Tbx3 null mESCs can be derived, and they maintain a stable self-renewing state and contribute to live chimeric embryos upon blastocyst injection.

Tbx3 Null mESCs Maintain an ESC-like Gene Expression Signature {#sec2.2}
--------------------------------------------------------------

To understand how ESC-like properties are maintained in the absence of Tbx3, we analyzed genome-wide mRNA expression profiles of Tbx3^+/+^, Tbx3^+/N^, and Tbx3^N/N^ cells using mRNA-Seq ([Table S1](#mmc2){ref-type="supplementary-material"}). Global gene expression profiles of Tbx3^+/+^, Tbx3^+/N^, and Tbx3^N/N^ cells are strongly correlated with each other (0.96--0.98). We asked whether genes important for maintenance of the ESC state changed between Tbx3^+/+^, Tbx3^+/N^, and Tbx3^N/N^ cells. To test this, we annotated a list of three ESC-specific gene sets. First, we looked at genes from published genome-wide RNAi screens in human and mouse ESCs that were found to be important for pluripotency, hereby-called "RNAi" set ([@bib8; @bib11; @bib14; @bib22; @bib24]). Second, we analyzed genes whose upstream DNA elements are bound by Oct4, Sox2, and Nanog (OSN), hereby-called "OSN" set. Third, we looked at genes with transcriptional start sites (TSSs) closest to mESC-specific super enhancers, hereby called "SE" set ([@bib7; @bib42; @bib68]). The genes from "RNAi "set are expressed at similar levels (correlation coefficient = 0.95) in Tbx3^+/+^ and Tbx3^N/N^ cells ([Figure 2](#fig2){ref-type="fig"}E). The mRNA expression pattern of the "RNAi" set genes between mESCs and mouse EBs (correlation coefficient = 0.72) is shown for comparison ([Figure 2](#fig2){ref-type="fig"}F) ([@bib18]). Also for genes from "OSN" and "SE" sets, mRNA expression levels correlated tightly (correlation coefficient = 0.95--0.96) between Tbx3^+/+^ and Tbx3^N/N^ cells ([Figures 2](#fig2){ref-type="fig"}G and 2H). We therefore, saw no significant changes in mRNA expression levels between Tbx3^+/+^ and Tbx3^N/N^ cells in any of the datasets tested ([Figure 2](#fig2){ref-type="fig"}I). In addition, we found comparable levels of key ESC proteins such as OCT4, SOX2, NANOG, ESRRB, CMYC, KLF4, and TCL1 in Tbx3^+/+^, Tbx3^+/N^, and Tbx3^N/N^ cells ([Figure 2](#fig2){ref-type="fig"}J). The levels of SSEA1, a key cell surface marker of mESCs, also did not change between Tbx3^+/+^, Tbx3^+/N^, Tbx3^N/N^, and Tbx3^N/P^ cells ([Figure 2](#fig2){ref-type="fig"}K). In conclusion, Tbx3 null mESCs maintain a functionally unchanged global transcriptional landscape in long-term cultures.

Tbx3 Transcriptionally Represses Dppa3 in mESCs {#sec2.3}
-----------------------------------------------

Our mRNA-Seq analysis revealed no global change in gene expression between Tbx3^+/+^, Tbx3^+/N^, and Tbx3^N/N^ cells. However, few genes were upregulated (\>2-fold) in Tbx3^N/N^ cells. *Dppa3* is one of those genes ([Figure 2](#fig2){ref-type="fig"}D). It is also upregulated in T3Blast^N/N^ cells ([Figure S3](#mmc1){ref-type="supplementary-material"}C). To investigate the molecular mechanism of Dppa3 induction, we expressed a Dox-inducible Tbx3 transgene ([Figure 3](#fig3){ref-type="fig"}A) into Tbx3^N/N^ cells, hereby called Tbx3^N/N^+Tg cells. Dox-induced *Tbx3* expression was verified at the mRNA and protein level ([Figures S4](#mmc1){ref-type="supplementary-material"}A and S4B). Tbx3 controls *Dppa3* mRNA expression in a concentration-dependent manner ([Figure 3](#fig3){ref-type="fig"}B). To confirm these results, we expressed Flag-Biotin-tagged Tbx3 (fbTbx3) transgene in Tbx3^N/N^ cells expressing the biotin ligase BirA transgene (Tbx3^N/N^+ BirA cells) ([Figures 3](#fig3){ref-type="fig"}C and 3D). The expression of the biotin ligase BirA allows for in vivo biotinylation of the tagged TBX3 protein ([@bib10; @bib29; @bib66]). Expression of fbTBX3 protein in Tbx3^N/N^+ BirA cells downregulated *Dppa3* mRNA expression ([Figure 3](#fig3){ref-type="fig"}E), while expression of other ESC TFs (*Nanog*, *Oct4*, *Rex1*) was unchanged. The effect of *Tbx3* expression on DPPA3 levels was also validated at the protein level using the cell lines discussed above ([Figure 3](#fig3){ref-type="fig"}F). *Dppa3* was also upregulated early upon shRNA-mediated depletion of *Tbx3* (Tbx3R-Dox) in a population of differentiating mESCs and in stable Tbx3 knockdown clones (clones 15, 16, 17; discussed in [Figure 1](#fig1){ref-type="fig"}) ([Figure 3](#fig3){ref-type="fig"}G). We next asked whether Tbx3 directly regulates the expression of Dppa3 using ChIP-Seq in mESCs. TBX3 protein binds ∼1.7 kb upstream of the *Dppa3* TSS ([Figure 3](#fig3){ref-type="fig"}H; [Table S2](#mmc3){ref-type="supplementary-material"}). We also tested the expression of *Tbx3* and *Dppa3* mRNAs in 45 single mESCs. We confirmed that both *Tbx3* and *Dppa3* are heterogeneously expressed in a population of self-renewing (SSEA1+) mESCs ([Figure 3](#fig3){ref-type="fig"}I; [Table S3](#mmc4){ref-type="supplementary-material"}), and their expression was anti-correlated (r = −0.61, p = 0.05) in cells that expressed *Tbx3* and *Dppa3* ([Figure 3](#fig3){ref-type="fig"}J). This anti-correlation of *Tbx3* and *Dppa3* expression in mESCs was also observed in other studies (r = −0.13; p = 0.03 in 185 cells) ([@bib30]). Tbx3 therefore transcriptionally represses *Dppa3* in mESCs and may contribute to the heterogeneity of Dppa3 expression.

Dppa3 is a marker of naive mESCs downregulated in epiblast stem cells (EpiSCs) ([@bib20; @bib61]) and during EB differentiation ([Figure S4](#mmc1){ref-type="supplementary-material"}C). We therefore asked whether Dppa3 overexpression compensates for absence of Tbx3 and helps to maintain the mESC state. We utilized our genetic complementation strategy ([@bib32]) and established Tbx3^N/N^ cells stably expressing an shRNA targeting Dppa3 as well as a Dox-inducible shRNA immune Dppa3 Tg, named Tbx3^N/N^-Dp3R ([Figure S4](#mmc1){ref-type="supplementary-material"}D). These rescue clones were generated in the presence of Dox ([Figure S4](#mmc1){ref-type="supplementary-material"}E). Upon removal of Dox, Tbx3^N/N^-Dp3R cells displayed a partially differentiated morphology ([Figure S4](#mmc1){ref-type="supplementary-material"}F) and decreased levels of the ESC marker SSEA1 ([Figure S4](#mmc1){ref-type="supplementary-material"}G). These changes were accompanied by increased expression of the mesoderm marker Brachyury (*T*) and decreased expression of the ESC markers *Tcl1* and *Esrrb* ([Figure S4](#mmc1){ref-type="supplementary-material"}H). Given this partial differentiation phenotype, it is likely that other factors besides Dppa3 also aid in the maintenance of the mESC state in the absence of Tbx3. Taken together, our results indicate that Dppa3 overexpression in Tbx3 null mESCs, at least in part, compensates for the function of Tbx3 in the maintenance of ESC state.

Tbx3 Controls Initiation of Wnt Signaling-Mediated Mesoderm Differentiation {#sec2.4}
---------------------------------------------------------------------------

We wanted to better understand the function of Tbx3 during the exit of mESCs from pluripotency toward differentiation. During exit from pluripotency, *Tbx3* expression is downregulated ([Figure S4](#mmc1){ref-type="supplementary-material"}I). *Tbx3* expression is also downregulated in mouse EpiSCs ([@bib61]) and mouse epiblast-like stem cells (EpiLCs) ([@bib4]). We used Wnt mediated serum-free derivation of mesoderm from mESCs to further assess levels of *Tbx3* ([Figure S4](#mmc1){ref-type="supplementary-material"}J) ([@bib25]). During 2 days of differentiation, mesoderm genes (*T*, *Mixl1*, *Wnt8a*) were upregulated ([Figure S4](#mmc1){ref-type="supplementary-material"}K), and other pluripotency-associated genes (*Nanog*, *Tcl1*) as well as *Tbx3* were downregulated ([Figure S4](#mmc1){ref-type="supplementary-material"}L).

We tested the ability of Tbx3 null mESCs to differentiate into the three germ layers using the EB differentiation assay. Absence of *Tbx3* expression in Tbx3^N/N^ cells is accompanied by overexpression of *Dppa3* ([Figure 4](#fig4){ref-type="fig"}A), a number of markers of ectoderm (*Mash1*/*Ascl1*, *Nes*) ([Figure 4](#fig4){ref-type="fig"}B), mesoderm (*T*, *Mixl1*, *Flk1*, *Tbx6*) ([Figure 4](#fig4){ref-type="fig"}C), and mesendoderm (*Cxcr4)* markers ([Figure 4](#fig4){ref-type="fig"}D). However, endoderm (*Gata6*, *Sox17*, *Foxa2*) and extraembryonic endoderm (*Sox7*, *Amn*) genes were significantly downregulated in EBs of Tbx3^N/N^ cells ([Figures 4](#fig4){ref-type="fig"}E and 4F), consistent with the reported role of Tbx3 in regulating extraembryonic endoderm differentiation ([@bib26; @bib38]). We confirmed these results by knocking down Tbx3 in mESCs using shRNA and testing its effect on EB differentiation ([Figure 4](#fig4){ref-type="fig"}G). *Tbx3* expression was downregulated, and *Dppa3* expression was significantly upregulated ([Figure 4](#fig4){ref-type="fig"}H). We saw significant upregulation of mesoderm (*T*, *Flk1*, *Mixl1*) and ectoderm (*Nes*) genes ([Figures 4](#fig4){ref-type="fig"}I and 4J), while endoderm gene (*Sox17*) was downregulated ([Figure 4](#fig4){ref-type="fig"}K). The same effect was also seen during differentiation of Tbx3 ^N/P^ cells. In absence of *Tbx3* expression ([Figure S5](#mmc1){ref-type="supplementary-material"}A), *Dppa3* was upregulated ([Figure S5](#mmc1){ref-type="supplementary-material"}B). The upregulation of mesoderm genes (*T*, *Tbx6*, *Wnt8a*) ([Figure S5](#mmc1){ref-type="supplementary-material"}C) and downregulation of endoderm genes (*Sox17*, *FoxA2*, *Gata6*, *Amn*, *Sox7*) ([Figure S5](#mmc1){ref-type="supplementary-material"}D) were confirmed. To confirm the effect at the protein level, we used a serum-free differentiation (SFD) protocol to direct mESCs to mesoderm progenitors ([Figure S5](#mmc1){ref-type="supplementary-material"}E). Mesoderm progenitors are ECADHERIN^−^ FLK1^+^ population ([@bib52; @bib70; @bib72]). A population of ECADHERIN^−^ mesoderm cells also expresses CXCR4 protein unlike endoderm cells that are ECADHERIN^+^CXCR4^+^ ([@bib72]). Therefore, to define mesoderm progenitors, we measured either ECADHERIN^−^ FLK1^+^ or ECADHERIN^−^ FLK1^+^ CXCR4^+^after 5--6 days of differentiation of Tbx3^+/+^, Tbx3^+/N^, and Tbx3^N/P^ cells ([Figure S5](#mmc1){ref-type="supplementary-material"}F). We see a significant upregulation of mesoderm differentiation in Tbx3^N/P^ cells compared with Tbx3^+/+^ cells ([Figure S5](#mmc1){ref-type="supplementary-material"}G). Tbx3 therefore represses differentiation into mesoderm lineage.

Furthermore, in ESC growth conditions, knockdown of Tbx3 in mESCs (shTbx3) causes a significant upregulation of mesoderm genes ([Figure 5](#fig5){ref-type="fig"}A). *T*, a primitive streak marker, is overexpressed in shTbx3 cells (∼60-fold) ([Figure 5](#fig5){ref-type="fig"}B). Wnt signaling regulates and is regulated by T expression during primitive streak emergence and early mesoderm formation ([@bib44; @bib49; @bib69]). We saw that shTbx3 cells have significantly increased expression of Wnt pathway genes ([Figures S6](#mmc1){ref-type="supplementary-material"}A). Specifically, *Wnt8a* and *Fzd2* mRNAs are upregulated in shTbx3 cells ([Figures 5](#fig5){ref-type="fig"}C and 5D). *Wnt8a* is expressed during early stages of mESC differentiation ([@bib35]) and in mesoderm progenitors of a developing embryo ([@bib49]). During a time course of EB differentiation, *Wnt8a* and *Fzd2* are significantly upregulated in EBs derived from Tbx3 null cells ([Figure 5](#fig5){ref-type="fig"}E) and in EBs derived upon knockdown of Tbx3 ([Figure 5](#fig5){ref-type="fig"}F). TBX3 protein also binds upstream of the *T*, *Wnt8a*, and *Fzd2* gene promoters in mESCs ([Figures 5](#fig5){ref-type="fig"}G--5I; [Table S2](#mmc3){ref-type="supplementary-material"}) directly repressing their expression.

Apart from its role in differentiation, Wnt signaling is known to promote pluripotency in ESC culture conditions. The addition of WNT3A into mESC culture media increased levels of *Tbx3* mRNA ([Figures S5](#mmc1){ref-type="supplementary-material"}B and S5C). A significant number of genes bound by TBX3 are also bound by β-CATENIN, a downstream effector of Wnt signaling ([Figure 5](#fig5){ref-type="fig"}J). We found that the TBX3 binding site upstream of the *T* promoter ([Figure 5](#fig5){ref-type="fig"}G) overlaps with a TCF binding motif previously shown to activate *T* expression during mesoderm differentiation ([@bib69]). This binding site is also co-bound by β- CATENIN upon Wnt stimulation ([Figure 5](#fig5){ref-type="fig"}G) in mESCs ([@bib75]) and mediates the differentiation of human ESCs and iPSCs into mesoderm lineage ([@bib45]). This region is also marked by repressive modification H3K27me3 in mESCs (encode data). A significant number of TBX3 and β-CATENIN co-bound genes are highly expressed in mESCs, including *Oct4*, *Nanog*, *Sox2*, and *Esrrb* ([Figure S5](#mmc1){ref-type="supplementary-material"}D). However, TBX3, β-CATENIN, and H3K27me3 co-bound genes are significantly upregulated upon knockdown of Tbx3, which included mesoderm genes such as *T*, *Wnt8a*, *Hes7* ([Figure 5](#fig5){ref-type="fig"}K). Therefore, Tbx3 along with β-catenin represses mesoderm and Wnt pathway genes required for initiation of mesoderm differentiation.

*Tbx3* is rapidly downregulated upon differentiation of mESCs and is subsequently upregulated during later stages of differentiation. To address the role of Tbx3 during the exit from pluripotency, we overexpressed Tbx3 in WT mESCs prior to and during differentiation ([Figure S6](#mmc1){ref-type="supplementary-material"}E). Overexpression of Tbx3 for 2 days prior to differentiation repressed expression of mesoderm genes (*T*, *Mixl1*, *Tbx6*) and Wnt genes required for mesoderm differentiation (*Wnt8a*, *Wnt3a*) ([Figure S6](#mmc1){ref-type="supplementary-material"}F). Collectively, these data indicate that Tbx3 plays two separate roles, one during exit from pluripotency where it represses mesoderm genes and another during gastrulation, as reported, where it promotes the development of a mesendoderm population ([@bib67]). In pluripotent Tbx3 null cells, but not in WT cells (data not shown), *Dppa3* is overexpressed and represses *T* and *Wnt8a* ([Figure S6](#mmc1){ref-type="supplementary-material"}G). Dppa3 therefore compensates for Tbx3 function in repressing mesoderm differentiation and maintains pluripotency in the absence of Tbx3. Taken together, these findings suggest Tbx3 orchestrates the exit of mESCs from pluripotency by directly regulating members of the Wnt signaling pathway and repressing expression of mesoderm genes ([Figures 6](#fig6){ref-type="fig"}A and 6B).

Discussion {#sec3}
==========

Many key pluripotency TFs bind within close proximity to specific genomic locations and therefore cooperatively control the expression of key genes ([@bib7]). Overlapping functional TF binding sites ([@bib68]) ensure the stability of the overall transcriptional network. At the same time, TF expression heterogeneity ([@bib5; @bib30; @bib39; @bib40; @bib51; @bib64]) allows the network to respond quickly and specifically to external differentiation cues. We expect there exists Tbx3 high and low self-renewing states in an ESC population. Such states maybe dynamic and possess different developmental potentials. In the absence of Tbx3, mESCs can self-renew in LIF containing media and maintain an alternate and stable pluripotent state. Like other ESC TFs such as Nanog and Sox2 ([@bib62]), Tbx3 maintains the pluripotent state and promotes differentiation into specific lineages like embryonic and extra-embryonic endoderm ([@bib26; @bib38]).

Using a loss-of-function approach, we identify direct versus indirect targets of Tbx3 in mESCs. Tbx3 maintains normal steady-state levels of Dppa3. In the absence of Tbx3, upregulation of Dppa3 in part contributes to the maintenance of a stable pluripotent state. Varying levels of Dppa3 in mESCs marks distinct developmental states ([@bib20]). The mechanisms by which expression heterogeneity of Dppa3 is maintained in mESCs have not been defined. Tbx3 prevents the overexpression of Dppa3 in mESCs and may contribute to its heterogeneous expression.

Downstream components of key signaling pathways such as Bmp/Smad, Lif/Stat ([@bib50; @bib65]), Wnt/β-catenin ([@bib17; @bib46]), and PI3K/Akt ([@bib51]) balance self-renewal and differentiation. External signaling cues integrate into a response generated by activation or repression of key lineage-specific TFs ([@bib7; @bib31; @bib47; @bib51]). *Tbx3* expression is regulated by key signaling cascades such as Bmp/Smad ([@bib7; @bib71]), Jak/Stat ([@bib7]), PI3K/Akt ([@bib51]), Grb2/Mapk ([@bib51]), and Wnt/β-catenin ([@bib56; @bib57]). Wnt signaling and Mapk inhibition in particular play important roles in pluripotency ([@bib60]) and mesoderm differentiation ([@bib15]). Activation of Wnt signaling by repression of GSK3β alone stimulates mesoderm differentiation from mESCs grown in ground state condition ([@bib25; @bib74]). In vivo loss-of-function studies demonstrate the requirement of Wnt signaling in the generation of primitive streak during gastrulation ([@bib63; @bib69]). Wnt signaling is transduced by regulation of TFs such as Tcf1 and Tcf3 ([@bib73; @bib75]). We show that downstream of Wnt signaling Tbx3 is required to repress premature differentiation of mESCs into mesoderm cells. We propose that the seemingly paradoxical functions of the Wnt signaling pathway in pluripotency versus differentiation are mediated in part through its control of *Tbx3* expression. In the absence of *Tbx3* expression, overexpression of *T* and Wnt pathway genes such as *Wnt8a* promotes mesoderm differentiation. Tbx3 therefore fine tunes the response of Wnt signaling to maintain the balance between pluripotency and mesoderm differentiation.

Recent studies indicated that overexpression of Tbx3 in differentiating cell populations promotes differentiation toward a mesendoderm fate ([@bib26; @bib67]). We show that overexpression of Tbx3 in mESCs prior to differentiation blocks emergence of mesoderm lineage ([@bib23; @bib38]). *Tbx3* expression is downregulated during the early stages of differentiation and upregulated at later stages ([@bib18; @bib20]). *Tbx3* expression is also highly downregulated during in vivo development of epiblast from the ICM and in the in vitro established EpiSCs and EpiLCs ([@bib3; @bib4; @bib61]). Tbx3 therefore has a dual role in blocking the premature exit from pluripotency by directly repressing mesoderm and Wnt pathway genes and at a later stage by promoting mesoderm differentiation during gastrulation.

Collectively, we suggest a model in which interplay of Tbx3 and Dppa3 regulates early differentiation decisions into mesoderm lineage by controlling components of Wnt pathway and mesoderm genes in response to external cues. The regulation of Dppa3 expression by Tbx3 in mESCs may act as a "buffer" to allow responses to varying concentrations of these two key TFs, thus maintaining a dynamic and responsive transcriptional landscape. Our model reconciles the dual role of Wnt signaling in maintaining the balance between mESC self-renewal versus differentiation. In conclusion, since Tbx3 is downstream of key signaling cascades and overlaps with many TF circuits understanding the direct versus indirect targets of Tbx3 and mechanisms by which it maintains pluripotency is vital to understanding the process of differentiation from self-renewing mESCs.

Experimental Procedures {#sec4}
=======================

Cell Culture {#sec4.1}
------------

The mESCs in the study were generated from R1, J1, AINV15, KH2, and CCE mESC lines. Tbx3 null mESCs were generated from Tbx3^+/N^ cells ([@bib9]). The procedures followed to make the lines are mentioned in greater detail in [Supplemental Information](#app2){ref-type="sec"}.

Differentiation Assays in Serum and Serum-free Conditions {#sec4.2}
---------------------------------------------------------

EB differentiation assay was performed in serum containing media without LIF by plating 0.5- to 2-million cells per well of a low attachment six-well plate over a time course of days. Serum-free mesoderm differentiation assay were performed as described ([@bib16]). Briefly, mESCs were plated in low attachment plates for 48 hr in SFD media and then replated in the same plates with VEGF (5 ng/μl), ACTIVIN A (25 ng/μl), and BMP4 (2.5 ng/μl). The cells were stained with respective antibodies ([Table S4](#mmc5){ref-type="supplementary-material"}) and analyzed by FACS described in [Supplemental Information](#app2){ref-type="sec"}.

ChIP-Seq and mRNA-Seq {#sec4.3}
---------------------

ChIP-Seq experiment was done as described ([@bib1]). mRNA-Seq experiment was done using the polyA pull down method as described in [Supplemental Information](#app2){ref-type="sec"}. Sequencing analysis for ChIP-seq and mRNA-seq data were performed in house as described in supplemental methods ([Tables S1](#mmc2){ref-type="supplementary-material"} and [S2](#mmc3){ref-type="supplementary-material"}). Raw data were deposited in Gene Expression Omnibus (GEO), accession number [GSE60066](ncbi-geo:GSE60066){#intref0010}.

Blastocyst Injection Assay {#sec4.4}
--------------------------

Indicated mESCs were injected into isolated C7Bl6 blastocysts and placed into pseudo-pregnant mice at the mouse genetics core at Mount Sinai. The embryos were harvested at E10.5, and pictures were taken using a florescence microscope. Mouse work was subject to approval by and carried out in accordance with guidelines from Mount Sinai's Institutional Animal Care and Use Committee.

Supplemental Information {#app2}
========================

Document S1. Supplemental Experimental Procedures, Figures S1--S6 and Table S6Table S1. mRNA-Seq Data from Tbx3^+/+^, Tbx^3+/N^, Tbx3^N/N^, shLuc, and shTbx3 Containing mESCs, Related to Figures 2 and 5Table S2. ChIP-Seq Targets of Tbx3 in mESCs, Related to Figures 2 and 5Table S3. Single-Cell mRNA-Seq Data of WT R1 mESCs, Related to Figure 3Table S4. Oligos and Antibodies Used in the Study, Related to Figures 1, 2, 3, 4, 5, and 6Table S5. T3blast mESC Lines and Embryo Counts, Related to Figure 2Document S2. Article plus Supplemental Information
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![Tbx3 Is Dispensable in a Subpopulation of mESCs\
(A) Picked long-term cultured Tbx3R mESC clones grown in presence (wDox) or absence (w/oDox) of Dox in ESC media containing LIF. BF, GFP channel, and AP staining colony pictures are shown. Scale bars represent 200 μM.\
(B) The mRNA expression signature of three independent Tbx3R-Dox mESC clones cultured in ESC media containing LIF. Data shown are the average of three independent clones for Tbx3R+Dox mESC.\
(C) TBX3 protein expression in Tbx3R mESC clones cultured in ESC media containing LIF. Quantification of protein levels is shown.\
(D) OCT4, SOX2, and TBX3 protein expression was checked by immunofluorescence (IF). Scale bars represent 200 μM.](gr1){#fig1}

![Tbx3 Null mESCs Express an ESC-like Gene Expression Signature\
(A) Tbx3 null mESCs maintain ESC-like morphology (top) and AP activity (bottom). Scale bars represent 200 μM.\
(B) Single Tbx3 null mESCs sorted into 96-well plates and assayed for their ability to form AP-positive colonies. Data represent the average of two independent plates.\
(C) Chimeric E10.5 embryos showing in vivo contribution of mESCs after blastocyst injection.\
(D) mRNA levels of indicated ESC markers in mESCs cultured in the presence of LIF. Data are the average of three independent experiments. ^∗^p \< 0.05 (t test).\
(E--H) Correlation of mESC-specific gene set between WT and Tbx3^N/N^ cells. Genes that have effects on mESC self-renewal from published genome-wide RNAi screens (E). Correlation of the same gene set between ESCs and EBs (G). Genes whose promoters are bounds by OCT4, SOX2, and NANOG (OSN) in mESCs from published datasets (F). Genes whose upstream or downstream DNA elements were described as ESC-specific super enhancers (H). "Corr" is the Pearson's correlation coefficient.\
(I) mRNA expression profile from normalized mRNA-Seq dataset from Tbx3^+/+^ and Tbx3^N/N^ mESCs for the indicated gene sets. The expression data are represented as quantile scores, described in [Supplemental Information](#app2){ref-type="sec"}. Significance calculated using Wilcoxon rank sum test with continuity correction.\
(J) Protein levels of indicated ESC markers in mESCs cultured in presence of LIF.\
(K) SSEA1-APC staining on mESCs grown in serum + LIF. IgM-APC stained cells used as negative control.](gr2){#fig2}

![Tbx3 Represses the Expression of Dppa3 in mESCs\
(A) Construct used for inducible expression of Tbx3 transgene in Tbx3 null mESCs.\
(B) *Tbx3* and *Dppa3* mRNA levels in Tbx3^+/+^ and Tbx3^N/N^+Tg cells treated with indicated concentrations of Dox/ml.\
(C and D) Constructs used in making Tbx3^N/N^ + BirA (C) and Tbx3^N/N^ + BirA + fbTbx3 (D) lines.\
(E) mRNA levels of indicated genes in Tbx3^+/+^, Tbx3^N/N^+BirA, and Tbx3^N/N^+BirA+fbTbx3 cells. Data are the average of three independent replicates. The p values were generated using t test.\
(F) DPPA3 protein expression in Tbx3^+/+^, Tbx3^+/N^, Tbx3^N/N^, Tbx3^N/P^, Tbx3^N/N^+Tg, Tbx3^N/N^+BirA, and Tbx3^N/N^+BirA+fbTbx3 cells.\
(G) mRNA expression profile from qRT-PCR experiment for the indicated genes. Tbx3R data are cells grown with or without Dox (Tbx3) over 5 days. Wild-type (Tbx3R+Dox) data are an average of three independent clones 27, 28, and 29 from [Figure 1](#fig1){ref-type="fig"}. Null (Tbx3R-Dox) data are an average of three independent clones 15, 16, and 17 from [Figure 1](#fig1){ref-type="fig"}.\
(H) TBX3 binds 1.7 kb upstream of the *Dppa3* TSS in mESCs.\
(I) *Tbx3* and *Dppa3* mRNA levels in SSEA1^+^ single mESCs.\
(J) Correlation of mRNA expression values in cells expressing *Dppa3* and *Tbx3*.](gr3){#fig3}

![Effect of Tbx3's Loss on Differentiation of mESCs\
(A--F) The mRNA expression pattern of indicated genes during a 12-day EB differentiation time course. Data are average of three independent replicates. ^∗^p \< 0.05 and ^∗∗^p \< 0.005 (t test).\
(G) Schematic of EB differentiation of mESCs after infection with the control shRNA or Tbx3 shRNA.\
(H--K) The mRNA expression pattern of indicated genes during a 12-day EB differentiation time course after infection with the control shRNA or Tbx3 shRNA. The data are an average of three independent replicates. ^∗^p \< 0.05 and ^∗∗^p \< 0.005 (t test).](gr4){#fig4}

![Tbx3 Represses Wnt Signaling-Mediated Mesoderm Differentiation\
(A) Gene set enrichment analysis (GSEA) to detect statistical significance of mesoderm genes in shTbx3 versus shLuc. Cells grown in ESC media containing LIF were infected with lentiviral shRNA constructs against Luciferase (shLuc) or Tbx3 (shTbx3).\
(B--D) mRNA-Seq FPKM values of *T*, *Wnt8a*, and *Fzd2* in cells infected the indicated shRNAs.\
(E) mRNA expression profile of indicated genes during EB differentiation time course of 12 days for indicated cell lines. Data are the average of three independent replicates. ^∗^p \< 0.05 and ^∗∗^p \< 0.005 (t test).\
(F) mRNA expression profile of the indicated genes during EB differentiation time course of 12 days in WT mESCs infected with indicated shRNAs. Data are the average of three independent replicates. ^∗^p \< 0.05 and ^∗∗^p \< 0.005 (t test).\
(G--I) TBX3 ChIP-seq binding data from N/N-BirA (control) and N/N-BirA+fbTbx3 cells. β-CATENIN binding from published data.\
(J) Venn diagram representing overlap between β-CATENIN and TBX3 genome-wide binding sites. The p value was generated using the fisher exact test.\
(K) GSEA to detect statistical significance of TBX3, β-CATENIN, and H3K27me3 co-bound gene set in shTbx3 versus shLuc.](gr5){#fig5}

![Tbx3-Mediated Repression of *Dppa3*, Mesoderm Genes, and Wnt Signaling Components Maintains the Balance between Self-renewal and Differentiation of mESCs\
(A) In WT mESCs, *Tbx3* controls expression of *Dppa3*, mesoderm genes, and Wnt signaling components to maintain mESC pluripotency.\
(B) In Tbx3 null mESCs, *Dppa3* is overexpressed and partially takes over function of *Tbx3* to repress mesoderm genes and Wnt signaling components to maintain mESC pluripotency.](gr6){#fig6}
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